"Multi-targeted Tyrosine Kinase Inhibitors Potently Suppress FLT3-ITD+ AML cell growth" Mark Weirand"Establishing the role of Prdx1 in CAF motility and ECM remodeling" Shireen Attaran
Mark Weir
Major Advisor: Thomas E. Smithgall, PhD
Shireen Attaran
Major Advisor: Steffi Oesterreich, PhD